Back to search

University of South Florida

Preliminary Characterization and Functional Validation of Pre-erythrocytic Vaccine Candidates for the Malaria Parasite Plasmodium vivax

Abstract

dc:description

RTS,S/AS01, vaccine targeting malaria caused by Plasmodium falciparum, used in moderate to high malaria transmission, provides hope for pre-erythrocytic (PE) subunit malaria vaccine development. Despite this vaccine advance, efforts to develop an efficacious vaccine against the neglected parasite Plasmodium vivax have lagged. In addition, there exists a gap in our understanding of PE antigens that can induce broadly-neutralizing antibodies. In this dissertation, we provide the preliminary characterization of vaccine candidates targeting the PE of P. vivax. Through transcriptomic profiling data and a target product profile, we identified critical P. vivax antigens (SSP3, SPECT-1, and M2-MAEBL) that can potentially be targets of neutralizing antibodies. We recombinantly expressed P. vivax PE antigens and utilized them in immunogenicity and seroprevalence studies. Our data suggest that these candidates have little variation and are surface exposed on P. vivax sporozoites. This dissertation also explores the predictive capability of PE in vitro assay outcomes to in vivo challenge outputs. As in vitro assays are used to screen therapeutic targets, we sought to validate these bioassays against a traditional transgenic mouse malaria in vivo challenge model. To answer this, we used two well-characterized species-specific monoclonal antibodies (mAbs) targeting circumsporozoite protein (CSP) along with two characterized transgenic P. berghei rodent lines (PbmCh-luc and Pb-PfCSP). Using the in vitro liver stage development assay (ILSDA), we generated a dose-response curve to determine the IC50 of anti-CSP mAbs. Next, we conducted an intravenous challenge of transgenic sporozoites after the passive transfer of mAbs in BALB/c mice. We report that antibody-mediated in vitro inhibition of characterized mAbs closely tracked a decrease in developing liver-stage schizonts in vivo. This study validates an experimental in vitro platform to evaluate novel P. vivax PE vaccine candidates and predict relative in vivo outcomes as a selection tool in advancing the best PE candidates for future discovery research.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Medicine
Grantor
University of South Florida
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Nicholas, Justin Lee, III
Contributors dc:contributor
  • John H. Adams, Ph.D.
  • Andreas Seyfang, Ph.D.
  • Burt Anderson, Ph.D.
  • Liwang Cui, Ph.D.
  • Bala Chandran, Ph.D.

Subjects

dc:subject × 7

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/10734

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Nicholas, Justin Lee, III. Preliminary Characterization and Functional Validation of Pre-erythrocytic Vaccine Candidates for the Malaria Parasite Plasmodium vivax. Dissertation thesis, University of South Florida, 2023. https://digitalcommons.usf.edu/etd/10734